Healthcare provider profile · identity verified

Michael Seidman, MD

Nephrology · OGDENSBURG, NY · NPI 1134188725

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	108
Hydrochlorothiazide	Hydrochlorothiazide	398	91
Amlodipine Besylate	Amlodipine Besylate	349	85
Levothyroxine Sodium	Levothyroxine Sodium	329	75
Pantoprazole Sodium	Pantoprazole Sodium	323	79
Furosemide	Furosemide	315	75
Omeprazole	Omeprazole	290	74
Rosuvastatin Calcium	Rosuvastatin Calcium	287	69
Losartan Potassium	Losartan Potassium	285	76
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	261	63
Citalopram Hbr	Citalopram Hydrobromide	238	55
Tamsulosin Hcl	Tamsulosin Hcl	211	56
Tramadol Hcl	Tramadol Hcl	209	52
Gabapentin	Gabapentin	208	50
Metoprolol Succinate	Metoprolol Succinate	204	58
Simvastatin	Simvastatin	199	52
Metformin Hcl	Metformin Hcl	195	50
Trazodone Hcl	Trazodone Hcl	190	41
Potassium Chloride	Potassium Chloride	184	51
Atenolol	Atenolol	181	39
Eliquis	Apixaban	170	41
Metoprolol Tartrate	Metoprolol Tartrate	168	46
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	166	53
Lisinopril	Lisinopril	149	38
Farxiga	Dapagliflozin Propanediol	145	29
Prednisone	Prednisone	143	57
Venlafaxine Hcl Er	Venlafaxine Hcl	134	30
Albuterol Sulfate Hfa	Albuterol Sulfate	126	40
Spironolactone	Spironolactone	123	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	23
Allopurinol	Allopurinol	107	24
Paroxetine Hcl	Paroxetine Hcl	105	22
Enalapril Maleate	Enalapril Maleate	101	26
Olanzapine	Olanzapine	98	17
Doxazosin Mesylate	Doxazosin Mesylate	95	24
Montelukast Sodium	Montelukast Sodium	94	27
Azithromycin	Azithromycin	87	67
Synthroid	Levothyroxine Sodium	85	19
Clopidogrel	Clopidogrel Bisulfate	81	25
Carvedilol	Carvedilol	79	15
Fluticasone Propionate	Fluticasone Propionate	77	31
Finasteride	Finasteride	72	16
Lorazepam	Lorazepam	70	14
Azelastine Hcl	Azelastine Hcl	66	22
Warfarin Sodium	Warfarin Sodium	66	14
Famotidine	Famotidine	63	14
Prosol	Parenteral Amino Acid 20% No.1	62	suppressed
Buspirone Hcl	Buspirone Hcl	61	12
Hydroxyzine Hcl	Hydroxyzine Hcl	61	13
Clonazepam	Clonazepam	59	suppressed
Donepezil Hcl	Donepezil Hcl	58	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	52	14
Dilt-Xr	Diltiazem Hcl	49	11
Triamcinolone Acetonide	Triamcinolone Acetonide	49	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	29
Nystatin	Nystatin	48	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Digoxin	Digoxin	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	12
Glyburide	Glyburide	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	40	11
Clonidine Hcl	Clonidine Hcl	40	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	13
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Trulicity	Dulaglutide	33	suppressed
Colchicine	Colchicine	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Ketoconazole	Ketoconazole	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Xarelto	Rivaroxaban	26	suppressed
Cephalexin	Cephalexin	25	20
Entresto	Sacubitril/Valsartan	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	17
Lamotrigine	Lamotrigine	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	suppressed
Ozempic	Semaglutide	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	21	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Potassium Citrate Er	Potassium Citrate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Victoza 3-Pak	Liraglutide	19	suppressed
Cefdinir	Cefdinir	18	18
Fluocinonide	Fluocinonide	18	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	16	suppressed
Metronidazole	Metronidazole	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Temazepam	Temazepam	15	suppressed
Calcium Acetate	Calcium Acetate	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Econazole Nitrate	Econazole Nitrate	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Invokana	Canagliflozin	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Vancomycin Hcl	Vancomycin Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Liraglutide	Liraglutide	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error